Bengaluru: BMCRI likely to suspend trials of Dr Giridhar Kaje’s ayurvedic tablets

Team Udayavani, Aug 2, 2020, 3:43 PM IST

Bengaluru: The ethics committee of the Bangalore Medical College and Research Institute (BMCRI) has issued a notice to Bengaluru-based ayurvedic medical practitioner named Dr Giridhar Kaje for claiming the success of the trials of tablets — Bhoumya and Saathmya – without presenting it to the committee.

The BMCRI has also decided to suspend the clinical trials for ayurvedic tablets — Bhoumya and Saathmya — which were introduced to cure COVID-19 by Dr Giridhar Kaje.

In a letter to Dr Kaje, BMCRI said, “Though the trial is still in its preliminary stage and no results have been placed before the ethics committee of BMCRI, you have gone to the public claiming success of the Trial. This is unacceptable and amounts to overstepping of one’s responsibility.”

“You must immediately clarify in the media the factual position as otherwise we will be force to suspend the trial due to the unauthorised act of yours in misleading the public,” the letter added.

However, Kaje has denied all the allegations.